FFT Wealth Management LLC acquired a new position in Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 395,774 shares of the company’s stock, valued at approximately $1,274,000. FFT Wealth Management LLC owned approximately 0.56% of Ovid Therapeutics as of its […]
Ovid Therapeutics (NASDAQ:OVID) Research Coverage Started at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright began coverage on shares of Ovid Therapeutics (NASDAQ:OVID – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $9.00 price objective on the stock. HC Wainwright also issued estimates for Ovid Therapeutics’ Q1 2024 earnings at ($0.22) EPS, Q2 2024 […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities research analysts at B. Riley issued their Q1 2024 earnings per share (EPS) estimates for shares of Ovid Therapeutics in a research note issued to investors on Monday, April 29th. B. Riley analyst K. Patel expects that the company will earn ($0.26) per share for the […]
Critical Review: Shattuck Labs (NASDAQ:STTK) versus Ovid Therapeutics (NASDAQ:OVID) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.